RUBRIK, INC.

RBRK

CIK 0001943896 · Quarterly mode · latest period FY2026 (Q4) (ending 2026-01-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q4)

Revenue
$378M
↑+46.3% +$120Mvs FY2025 (Q4)
Operating Income
$195M
↑+78.1% +$86Mvs FY2025 (Q4)
Net Income
$178M
↑+80.9% +$79Mvs FY2025 (Q4)
Gross Profit
$308M
↑+54.3% +$108Mvs FY2025 (Q4)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Excellent
82/100
  • Profitability
    100ROIC 50.8% (10% = solid, 20%+ = moat)
  • Liquidity
    60Current Ratio 1.69 (above 1.5 = solid)
  • Leverage
    100D/E -0.58 (under 0.5 = conservative)
  • Efficiency
    33Asset Turnover 0.63x (1.0+ = capital-efficient)
  • Growth
    100Revenue YoY +46.3% (10% = solid, 25%+ = elite)
  • Margin Trend
    100Op Margin -21.6% · trend +145.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project RBRK's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$22.18
Total enterprise IV
$4.36B
Diluted shares
0.20B
Terminal PV
$3.16B (72% of total)
Year-5 FCF
$372M
YearProjected FCFDiscounted PV
+1$274M$249M
+2$295M$244M
+3$319M$240M
+4$345M$235M
+5$372M$231M
Terminal$5.09B$3.16B

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$30M
investment in PP&E
Stock-based comp (TTM)
$329M
non-cash dilution

Balance sheet · 2026-01-31

latest filed snapshot
Total assets
$2.77B
everything owned
Total liabilities
$3.29B
everything owed
Stockholders' equity
$-520M
shareholder claim
Net debt
$-57M
Net cash position ($57M)

Recent performance · 13 quarters

Revenue↑+46.3% +$120M
$378M
Net Income↑+51.2% +$67M
$-64M
Free Cash Flow↓-4.5% -$4M
$75M
Operating Margin↑+31.3pts
-21.6%

Drill down